Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy
封锁
癌症研究
胶质瘤
医学
药理学
化学
受体
内科学
作者
Ting Sun,Bin Liu,Lize Cai,Youxin Zhou,Wei Yang,Yanyan Li